LLY vs ELV
By Alex · Tickerpine
Eli Lilly and Company vs Elevance Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | ELV |
|---|---|---|
| Price | $1,183.46 | $396.09 |
| Market cap | $1.06T | $85.90B |
| P/E ratio | 39.7 | 17.5 |
| ROE | 102.29% | 11.13% |
| Profit margin | 33.53% | 2.47% |
| Revenue growth | 47.70% | 1.40% |
| Dividend yield | 0.58% | 1.74% |
| Beta | 0.50 | 0.70 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs ELV in plain English
- LLY is the bigger company — about 12.3× the market cap of ELV.
- ELV is cheaper on earnings (P/E 17.5 vs 39.7).
- LLY earns a higher return on equity (102% vs 11%).
- LLY is growing revenue faster (48% vs 1%).
- ELV has the higher dividend yield (1.74% vs 0.58%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
ELV return calculator
See what $1,000 in Elevance Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.